Abstract:The effects of indole-3-propionic acid (IPA) on intestinal microbiota and metabolic parameters in high-fat diet-induced obese mice were investigated through a study where male C57BL/6J mice were randomly divided into three groups: a low-fat diet group (LFD), a high-fat diet group (HFD), and an IPA intervention group (HFD+IPA). Alterations in body weight, liver weight, and peritesticular adipose tissue weight were measured, and lipid deposition was observed following 16 weeks of intragastric administration. Serum triglyceride (TG) and total cholesterol (TC) levels were determined using the ELISA method. The composition and abundance of intestinal microbiota were analyzed through 16S rRNA sequencing. The results indicated that, compared with the HFD group, IPA intervention significantly reduced body weight gain (P<0.05), liver weight, and peritesticular adipose tissue weight by 26.30%, 29.00%, and 26.98%, respectively. Serum TG and TC levels decreased by 23.11% and 19.53%, respectively. The relative abundance of Akkermansia in the intestinal microbiota increased by 2-fold. These findings suggest that IPA may ameliorate metabolic abnormalities in obese mice by modulating the abundance of beneficial microbiota such as Akkermansia, providing a theoretical basis and potential application prospects for targeting gut microbiota with tryptophan metabolites to intervene in obesity.